Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – FDA (biotech/pharma) External News
FDA dings Alar over ‘extremely concerning’ ketamine claims - fiercepharma.com
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals (NASDAQ: JAZZ) director may sell 3,507 shares - Stock Titan
Google News – Pharmaceuticals External News
ESC 2026: Aficamten breaks new ground in nonobstructive HCM - Pharmaceutical Technology
Google News – Pharmaceuticals External News
Jazz Pharma (NASDAQ: JAZZ) director may sell 3,507 shares - Stock Titan
Google News – FDA (biotech/pharma) External News
T-Maximum Gains FDA Fast Track Status for CAR-T Glioblastoma Therapy - Contract Pharma
Google News – Pharmaceuticals External News
Jazz Pharma (NASDAQ: JAZZ) director to sell 3,507 shares - Stock Titan
Google News – Pharmaceuticals External News
Jazz Pharma (NASDAQ: JAZZ) director plans sale after 18,000 shares sold - Stock Titan
Google News – FDA (biotech/pharma) External News
FDA Approves PharmaEssentia’s Besremi for Adults with Rare Blood Cancer - Contract Pharma
Google News – Biopharma External News
Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum - BioPharma APAC
Google News – Biopharma External News
WuXi AppTec Raises 2026 Interim Dividend to RMB 1.51 Billion Amid Global CRDMO Expansion - BioPharma APAC
Google News – Clinical Trials External News
Data4Life, Monash Health Partner to Accelerate Clinical Trials and Real-World Evidence Generation - BioPharma APAC
Google News – Biopharma External News
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - Kalkine Media
Google News – Biopharma External News
Single-Use Comes of Age--What Comes Next? - Genetic Engineering and Biotechnology News
Google News – Pharmaceuticals External News